RxDoctor Payments Data

Amy Muchowicz

Nurse Practitioner · Omaha, NENPI 1245518661

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $75,328 of the $78,467 with a category attached, or 96.0%. Organon accounts for 90.9% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $34,540 and has fallen 99.5% since, to $186 in 2025. Among nurse practitioner clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$78,467in general payments, 2019–2025

Across 228 payments — averaging $344.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organon$71K
  • Merck$5K
  • AbbVie$1K
  • Galderma Laboratories, L.p.$518

What the payments were for

  • Speaking & faculty fees$75,32896%
  • Travel & lodging$3820%
  • Food & beverage$2,7403%
  • Education$170%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Organon155$71,347
Merck9$5,336
AbbVie(2 entities)49$1,265
Galderma Laboratories, L.p.15$518

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$78,467 in reported general payments places this provider in the 95th percentile of 924 nurse practitioner providers in Nebraska.

See all nurse practitioner providers in Nebraska

Other nurse practitioner in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →